Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03358290 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Difficulty faced with enrollment in the study

Conditions

Plaque Psoriasis
Skin Diseases

Interventions

DRUG: JTE-051
DRUG: Placebo

Sponsor

Akros Pharma Inc.